Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy

Phase 2

Completed

Conditions: HIV
Contraception

Interventions: Drug: Levonorgestrel
Drug: Nevirapine
Drug: Efavirenz

First Posted Date: 2013-02-12

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 60

Registration Number: NCT01789879

Locations: 🇺🇬
Infectious Diseases Institute, Kampala, Uganda

Echo-guided Hemodynamic Management Strategy in Elderly Patients Undergoing Noncardiac Surgery

Not Applicable

Completed

Conditions: Ventricular Dysfunction, Left
Major Adverse Cardiac Events

Interventions: Procedure: EGHEM

First Posted Date: 2013-01-31

Last Posted Date: 2023-09-15

Lead Sponsor: University of Nebraska

Target Recruit Count: 97

Registration Number: NCT01780727

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Smokers' Response to Nicotine Dependence Genotyping

Not Applicable

Completed

Conditions: Nicotine Dependence
Cigarette Smoking

Interventions: Behavioral: Receipt of Genetic Results
Behavioral: No results given

First Posted Date: 2013-01-30

Last Posted Date: 2024-10-31

Lead Sponsor: University of Nebraska

Target Recruit Count: 24

Registration Number: NCT01780038

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart

Terminated

Conditions: Diastolic Heart Failure

First Posted Date: 2013-01-29

Last Posted Date: 2023-08-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 37

Registration Number: NCT01778894

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital

Completed

Conditions: Paraesophageal Hernia
Gastroesophageal Reflux Disease
Hiatal Hernia

First Posted Date: 2013-01-28

Last Posted Date: 2023-09-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 69

Registration Number: NCT01776827

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Heart Failure Exercise And Resistance Training Camp (HEART Camp)

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Behavioral: Heart Camp Group
Behavioral: Attention Control Group

First Posted Date: 2013-01-18

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 42

Registration Number: NCT01771900

Locations: 🇺🇸
BryanLGH Heart Institute, Lincoln, Nebraska, United States

Platelet Inhibition in Patients With Systolic Heart Failure

Phase 4

Completed

Conditions: Systolic Heart Failure

Interventions: Drug: Prasugrel 10 mg daily x 2 weeks
Drug: Clopidogrel 75 mg daily x 2 weeks

First Posted Date: 2013-01-10

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 30

Registration Number: NCT01765400

Locations: 🇺🇸
University of Nebaska Medical Center, Omaha, Nebraska, United States

Care4U: Self Management Intervention for Older Adult Caregivers

Not Applicable

Completed

Conditions: Cardiovascular Risk Factor

Interventions: Behavioral: Care4U

First Posted Date: 2013-01-09

Last Posted Date: 2023-09-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 6

Registration Number: NCT01764399

Locations: 🇺🇸
Bryan Health, Lincoln, Nebraska, United States

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Phase 2

Active, not recruiting

Conditions: Estrogen Receptor Negative
Estrogen Receptor Positive
HER2/Neu Negative
HER2/Neu Positive
Invasive Breast Carcinoma
Progesterone Receptor Negative
Progesterone Receptor Positive
Stage IA Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer

Interventions: Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Other: Laboratory Biomarker Analysis
Drug: Paclitaxel
Radiation: Radiation Therapy
Procedure: Therapeutic Conventional Surgery
Biological: Trastuzumab

First Posted Date: 2012-12-17

Last Posted Date: 2024-12-12

Lead Sponsor: University of Nebraska

Target Recruit Count: 92

Registration Number: NCT01750073

Locations: 🇺🇸
Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States
🇺🇸
CHI Health Saint Francis, Grand Island, Nebraska, United States
🇺🇸
Nebraska Medicine-Village Pointe Cancer Center, Omaha, Nebraska, United States

and more 1 locations

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Phase 1

Conditions: Pan-uveitis
Posterior Uveitis
Intermediate Uveitis

Interventions: Drug: Tocilizumab

First Posted Date: 2012-10-30

Last Posted Date: 2017-04-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 36

Registration Number: NCT01717170

Locations: 🇺🇸
Truhlsen Eye Institute, University Of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy